![Jean-Gabriel Judde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Gabriel Judde
Fondateur chez XenTech SAS
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Pascal Leuraud | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | 18 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Arnaud Beurdeley | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Marie-Emmanuelle Legrier | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Bertrand Coulomb | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Jean-Marc Husson | M | - |
Université Paris Diderot-Paris 7
| 3 ans |
Delphine Nicolle | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Ludovic Bourre | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Sabrina Serpillon | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Paola Bazzacco | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Jerome Cheng | M | 70 |
Université Paris Diderot-Paris 7
| 4 ans |
Antoine Petit | M | 64 |
Université Paris Diderot-Paris 7
| 3 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
France | 11 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Jean-Gabriel Judde
- Réseau Personnel